Author(s): Avijeet J. Zalte, Rajendra K. Surawase

Email(s): ajzalte19@gmail.com

DOI: 10.52711/2231-5691.2024.00018   

Address: Avijeet J. Zalte*, Rajendra K. Surawase
Department of Pharmaceutics, Loknete Dr. J. D. Pawar College of Pharmacy Manur, Nashik 423501, Maharashtra, India.
*Corresponding Author

Published In:   Volume - 14,      Issue - 2,     Year - 2024


ABSTRACT:
Objective: This study was intended to investigate the formulation and characterization of Mesalamine or 5-Aminosalicylic acid (5-ASA) pellets using novel excipient and formulated as matrix spheres to controlled the drug release extended period of time. Uniformly distributed throughout the gastrointestinal tract and Avoid dose dumping of drug. Methods: Mesalamine's active pharmaceutical component was characterised, and investigations were conducted prior to formulation to ensure a physical combination of the drug and excipients was achieved. Formulation of mesalamine as matrix pellets by using fluid bed processor and mesalamine loaded into seal coated sugar spheres and extended-release coating with Ethyl cellulose. Ethyl cellulose is pH independent polymer and retarder the drug release throughout the gastrointestinal tract and site-specific action in colon. Hypromellose also act as pore former and drug release based on diffusion mechanism. In drug layering, core pellets contain stearic acid and hydrogenated castor oil internally forming a matrix. Developed mesalamine pellets are characterized such as drug content, invitro drug release and appearances and particle size distribution. Results: Development of Mesalamine pellets based on five strategy From MEZ 1 to MEZ 5 are formulated and Characterization are performed. Based on the invitro drug release studies, we concluded that the formulation MEZ-IV was best formulation. Invitro drug release is consistence throughout 12hours.(1hrs-23%, 2nd hrs 41%, 4hrs-73, 6hrs-86, 8hrs-99% and 12hrs-10.


Cite this article:
Avijeet J. Zalte, Rajendra K. Surawase. Formulation and Characterization of Colon Targeted Mesalamine Pellets. Asian Journal of Pharmaceutical Research. 2024; 14(2):107-3. doi: 10.52711/2231-5691.2024.00018

Cite(Electronic):
Avijeet J. Zalte, Rajendra K. Surawase. Formulation and Characterization of Colon Targeted Mesalamine Pellets. Asian Journal of Pharmaceutical Research. 2024; 14(2):107-3. doi: 10.52711/2231-5691.2024.00018   Available on: https://asianjpr.com/AbstractView.aspx?PID=2024-14-2-3


REFERENCES:
1.    Walz M, Hagemann D, Trentzsch M, Weber A, Henle T. Degradation studies of modified inulin as potential encapsulation material for colon targeting and release of mesalamine. Carbohydrate Polymers. 2018; 199: 102-8.
2.    P. B. Patil, A. A. Hajare, R. P. Awale. Development and Evaluation of Mesalamine Tablet Formulation for Colon Delivery. Research J. Pharm. and Tech. 2011; 4(11): 1751-1756.
3.    Ashish Y. Pawar, Rahul A. Ahirrao. Formulation and Evaluation of Colon Targeted Drug Delivery System of Mesalamine Using Wet Granulation. Research J. Pharm. and Tech. 2014; 7(11): 1270-1279.
4.    Komal S. Lavhate, Rahul S. Solunke, Kore K. J., Rajkumar V. Shete, Madhuri T. Deshmukh. Development and Characterization of Mesalamine Microsphere for Colon Specific Drug Delivery. Research J. Pharm. and Tech. 2020; 13(4): 1747-1751.
5.    S. Sudarshan, S. Sangeeta, NR Sheth, P. Roshan, YV Ushir, R. Gendle. Colon Specific Drug Delivery System of Mesalamine for Eradication of Ulcerative Colitis. Research J. Pharm. and Tech. 2009; 2(4): 819-823.
6.    Sagar D. Kadam, Shashikant Dhole, Sohan Chitlange. Formulation and Evaluation of Sustained Release Colon Targeted Mesalamine Tablet. Research J. Pharm. and Tech. 2020; 13(5): 2241-2245.
7.    Irfan Ansari, Sachin Bhusari, Avinash Chaudhary, Gaurav Shrangare. Formulation and Evaluation of sustained release pellets of Zidovudine by using Extrusion and Spheronization Technique. Asian J. Res. Pharm. Sci. 2020; 10(4): 241-247.
8.    Gavaskar Basani, Madhusudan Rao Yamsani, Ramya Sri Sura. Formulation Development and Evaluation of Multiple Unit Pellet System of Tamsulosin Hydrochloride. Research Journal of Pharmacy and Technology. 2021; 14(10): 5319-4.
9.    Suresh Kolli, K. Vijayasri, P.N. Murthy. Formulation and invitro evaluation of delayed release multiple unit pellets of Lansoprazole in capsules. Research Journal of Pharmacy and Technology. 2021; 14(5): 2625-0.
10.    Rupam A. Wagh, Rajendra K. Surawase. Formulation and Development of Sustained Release Pellets of Nifedipine by Fluidized Bed Processor. Research J. Pharm. and Tech. 2020; 13(4): 1757-1761.
11.    Sangram M. Patil, Rakesh V. Mishra, Satish V. Shirolkar. Development and Evaluation of Sustain Release Simvastatin Pellets. Research J. Pharm. and Tech. 2017; 10(8): 2467-2473.
12.    https://www.drugfuture.com/Pharmacopoeia/usp35/PDF/38173818%20Mesalamine%20Extended-Release%20Capsules.pdf
13.    Suresh Kolli, K. Vijayasri, P.N. Murthy. Formulation and invitro evaluation of delayed release multiple unit pellets of Lansoprazole in capsules. Research Journal of Pharmacy and Technology. 2021; 14(5): 2625-0.


Recomonded Articles:

Author(s): Habeeb Ahmed, Mohammed Ehtesham, Nuha Rasheed , Abdul Saleem Mohammad

DOI: 10.5958/2231-5691.2017.00006.5         Access: Open Access Read More

Author(s): Hiral A. Makadia, Ami Y. Bhatt, Ramesh B. Parmar, Ms. Jalpa S. Paun, H.M. Tank

DOI:         Access: Open Access Read More

Author(s): S.C. Shivhare, U.D.Shivhare, Preeti Srivastav, K.G. Malviya

DOI:         Access: Open Access Read More

Author(s): Nikita R. Nikam, Rohan R. Vakhariya, Dr. C. S. Magdum

DOI: 10.5958/2231-5691.2019.00018.2         Access: Open Access Read More

Author(s): B.A. Bhairav, J.K. Bachhav, R.B. Saudagar

DOI: 10.5958/2231-5691.2016.00025.3         Access: Open Access Read More

Author(s): Sandesh Narayan Somnache, Ajeet Madhukar Godbole, Pankaj Sadashiv Gajare, Sapna Kashyap

DOI: 10.5958/2231-5691.2016.00028.9         Access: Open Access Read More

Author(s): Rutuja S. Shah, Rutuja R. Shah, Manoj M. Nitalikar, Chandrakant S. Magdum

DOI: 10.5958/2231-5691.2017.00024.7         Access: Open Access Read More

Author(s): Subhashis Debnath, C. Navya Yadav, N. Nowjiya, M. Prabhavathi, A. SaiKumar, P. Sai Krishna, M. Niranjan Babu

DOI: 10.5958/2231-5691.2019.00009.1         Access: Open Access Read More

Author(s): Mercy Mathew, Ravikumar, Simila Madathil, Anju Govind, Narayana Swamy VB

DOI: 10.5958/2231-5691.2016.00015.0         Access: Open Access Read More

Author(s): Manohar D. Kengar, Kiran K. Patole, Akshay K. Ade, Sumesh M. Kumbhar, Chetan D. Patil, Ashutosh R. Ganjave

DOI: 10.5958/2231-5691.2019.00019.4         Access: Open Access Read More

Author(s): Ashok B. Patel, Ashish H. Asnani, Amitkumar J. Vyas, Nilesh K. Patel, Ajay I. Patel, Arvind N. Lumbhani

DOI: 10.52711/2231-5691.2021.00034         Access: Open Access Read More

Author(s): Rina G. Maskare, Ayush P. Agrawal, Mayuri S. Pal, Jidnyasa R. Yerne, Megham Chaudhri, Anup R. Bawankar, Gaytri B. Sonkusre

DOI: 10.52711/2231-5691.2022.00025         Access: Closed Access Read More

Author(s): Vidya Raju*, Jasmine Joy Bell, Merlin. N. J, Shaiju S Dharan

DOI: 10.5958/2231-5691.2017.00037.5         Access: Open Access Read More

Author(s): Sheetal B. Gondkar, Shalaka P. Rasal, Ravindra B. Saudagar

DOI: 10.5958/2231-5691.2016.00027.7         Access: Open Access Read More

Author(s): Sahil Hasan, Saloni Bhandari, Anshu Sharma, Poonam Garg

DOI: 10.52711/2231-5691.2021.00047         Access: Open Access Read More

Asian Journal of Pharmaceutical Research (AJPRes.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. AJPRes. publishes Original Research Articles, Short Communications..... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5691 


Recent Articles




Tags